BD 263910 - Difco Incomplete Freund Adjuvant, Laboratory Research Adjuvant for Immunology Applications, 6/PK (Temp Sensitive; Non-Returnable) (Continental US Only)
The BD 263910 Difco Incomplete Freund Adjuvant is a specialized laboratory reagent designed for professional research and immunology applications. Incomplete Freund Adjuvant is commonly used in research settings to help support antigen presentation and immune response studies when combined with appropriate antigen preparations under validated laboratory protocols.
This product is intended for use by trained laboratory and research personnel only. It is commonly selected for immunology research, vaccine development studies, antibody production workflows, and controlled experimental models where an oil-based adjuvant system is required. It should be used strictly according to institutional animal care requirements, approved research protocols, and applicable safety procedures.
BD 263910 is not intended for direct clinical treatment, human administration, diagnostic use, or therapeutic use. Buyers should confirm current availability, documentation requirements, storage guidance, and suitability for the intended research protocol before ordering.
| Manufacturer | 263910 |
| Application | Adjuvant |
| Cultivation or Test Type | Used to Prepare Antigen-adjuvant Emulsions |
| olume | 6 X 10 mL |
Key Benefits
BD 263910 Difco Incomplete Freund Adjuvant supports research workflows where consistent adjuvant performance is important for immunological studies. Its formulation is designed for use in antigen-adjuvant emulsions that help researchers study immune response development under controlled experimental conditions.
The product is useful for laboratories that require a recognized adjuvant source for antibody production, immunization studies, and related preclinical research applications. Its use can help support protocol consistency when handled and prepared according to validated laboratory procedures.
As part of the BD Difco product portfolio, this adjuvant is suitable for research facilities that value established sourcing, lot traceability, and dependable documentation for regulated or protocol-driven laboratory environments.
Compatibility and Applications
BD 263910 Difco Incomplete Freund Adjuvant is compatible with research workflows requiring preparation of antigen-adjuvant emulsions. It should be used only with appropriate antigen materials, validated preparation techniques, approved study designs, and institutional oversight.
Common applications include immunology research, antibody production support, antigen response studies, vaccine-related research, preclinical immune response evaluation, and laboratory protocols involving controlled immunization models.
This product is typically used in academic research laboratories, biotechnology research facilities, pharmaceutical research departments, contract research organizations, veterinary research settings, and institutional animal research facilities. It is not intended for routine clinical use, patient care, direct injection into humans, or over-the-counter applications.
Usage Guidelines
Use BD 263910 Difco Incomplete Freund Adjuvant only by trained research professionals following approved protocols, institutional biosafety procedures, and animal care and use committee requirements where applicable.
Before use, confirm the product identity, lot number, expiration date, storage condition, and suitability for the intended research application. Prepare antigen-adjuvant emulsions according to the validated study protocol, using appropriate sterile technique, calibrated equipment, and approved handling procedures.
Do not use the product if the container is damaged, expired, contaminated, improperly stored, or if the contents show unexpected changes in appearance. Follow all manufacturer instructions, institutional safety procedures, and applicable regulatory requirements for handling, preparation, administration within approved research models, and disposal.
Certifications and Safety Standards
BD 263910 Difco Incomplete Freund Adjuvant is manufactured for professional laboratory and research use. Facilities should handle it in accordance with institutional laboratory safety standards, biosafety requirements, animal research protocols, and manufacturer guidance.
Research teams should maintain documentation for lot number, expiration date, storage conditions, protocol approval, preparation records, and use history. Buyers should verify current product labeling, safety data sheet, certificate of analysis availability, and compliance documentation through BD, CIA Medical, or authorized product documentation before use.
Comparison with Competitors
Compared with generic incomplete Freund adjuvant products, BD 263910 Difco Incomplete Freund Adjuvant offers the advantage of being part of BDs established Difco laboratory reagent portfolio. This may be important for laboratories that require recognized sourcing, consistent documentation, lot traceability, and protocol continuity.
Compared with complete Freund adjuvant formulations, incomplete Freund adjuvant does not include the mycobacterial component typically associated with complete formulations. This makes it suitable for specific research protocols where incomplete adjuvant is required, often for booster immunizations or study designs where the complete formulation is not appropriate.
Compared with newer synthetic or alternative adjuvant systems, Incomplete Freund Adjuvant remains a widely recognized research tool in established immunology workflows. The preferred product choice should be based on the study objective, species, antigen type, immune response target, institutional guidance, and ethical approval requirements.
Typical User Profile and Application Scenarios
The typical users of BD 263910 Difco Incomplete Freund Adjuvant include immunology researchers, laboratory scientists, antibody production teams, preclinical research staff, veterinary research professionals, pharmaceutical research teams, biotechnology personnel, and contract research organization staff.
This product is most relevant in research environments where controlled immune response studies or antibody production protocols are performed. Common scenarios include antigen booster studies, immunological response evaluation, research antibody development, preclinical vaccine investigations, and laboratory models requiring an oil-based adjuvant system.
Best Practices for Use and Maintenance
Store BD 263910 Difco Incomplete Freund Adjuvant according to manufacturer recommendations and institutional procedures. Keep the container closed when not in use and protect the product from contamination, improper temperature exposure, and unsuitable storage conditions.
Use appropriate personal protective equipment when handling the product. Prepare emulsions carefully according to validated protocols to support consistency and reduce preparation variability. Use sterile or aseptic technique where required by the protocol and avoid cross-contamination between materials.
Document lot number, opening date, expiration date, storage conditions, preparation details, and use records according to facility policy. Do not use material that appears compromised or has been stored outside recommended conditions.
Dispose of unused product, contaminated materials, sharps, and biological waste according to institutional laboratory safety procedures, animal research protocols, and applicable federal, state, and local regulations.
Regulatory and Safety Information
BD 263910 Difco Incomplete Freund Adjuvant is intended for professional laboratory research use only. It is not intended for direct patient administration, clinical treatment, diagnostic use, food use, or therapeutic application.
Personnel should follow all applicable safety requirements, including proper personal protective equipment, safe handling practices, spill management, labeling, storage documentation, and waste disposal procedures. When used in animal research, all procedures should be reviewed and approved through the appropriate institutional animal care and use process before implementation.
Facilities should review the current safety data sheet, product labeling, certificate of analysis, and relevant quality documentation before use. Compliance requirements may vary depending on whether the product is used in academic research, biotechnology development, pharmaceutical research, contract research, or institutional animal study workflows.
How to Order
Select the BD 263910 Difco Adjuvant Incomplete Freund and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, availability checks, or further assistance, contact CIA Medical customer service at (312) 275-5850 or use the contact form on this page.
